Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;93(6):539-46.
doi: 10.1038/clpt.2013.24. Epub 2013 Feb 11.

Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system

Affiliations

Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system

R Harpaz et al. Clin Pharmacol Ther. 2013 Jun.

Abstract

Signal-detection algorithms (SDAs) are recognized as vital tools in pharmacovigilance. However, their performance characteristics are generally unknown. By leveraging a unique gold standard recently made public by the Observational Medical Outcomes Partnership (OMOP) and by conducting a unique systematic evaluation, we provide new insights into the diagnostic potential and characteristics of SDAs that are routinely applied to the US Food and Drug Administration (FDA) Adverse Event Reporting System (AERS). We find that SDAs can attain reasonable predictive accuracy in signaling adverse events. Two performance classes emerge, indicating that the class of approaches that address confounding and masking effects benefits safety surveillance. Our study shows that not all events are equally detectable, suggesting that specific events might be monitored more effectively using other data sources. We provide performance guidelines for several operating scenarios to inform the trade-off between sensitivity and specificity for specific use cases. We also propose an approach and demonstrate its application in identifying optimal signaling thresholds, given specific misclassification tolerances.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest/Disclosure

No conflicts to disclose.

Figures

Figure 1
Figure 1
Signal detection algorithm performance based on the Area Under the Receiver Operating Characteristic curves (AUC) metric. LR, Logistic regression; ELR, Extended Logistic Regression; MGPS, Multi-item Gamma Poisson Shrinker; PRR, Proportional Reporting Ratio; ROR, Reporting Odds Ratio. Signal score labels suffixed by ‘05’ (lower bound signal scores) represent the lower 5% of their corresponding point estimate distributions. Error bars reflect AUC 95% confidence intervals.
Figure 2
Figure 2
Receiver Operating Characteristic (ROC) curves for the EB05, PRR05, ROR05, LR05, and ELR05 signal scores. The pattern of containment between logistic regression and disproportionality based methods imply that the class of logistic regression based approaches provides greater specificity across all levels of sensitivity.
Figure 3
Figure 3
Signal detection algorithm performance (AUC) classified by event. Error bars reflect AUC 95% confidence intervals. AUC, Area Under the Receiver Operating Characteristic curve.

Comment in

References

    1. [accessed Oct 2012];Adverse Event Reporting System. http://www.fda.gov/cder/aers/default.htm.
    1. Szarfman A, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf. 2002;25(6):381–392. - PubMed
    1. Szarfman A, Tonning JM, Doraiswamy PM. Pharmacovigilance in the 21st century: new systematic tools for an old problem. Pharmacotherapy. 2004;24(9):1099–1104. - PubMed
    1. Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18(6):427–436. - PubMed
    1. Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012;91(6):1010–1021. - PMC - PubMed

Publication types

MeSH terms